Press Releases

Traceable® Top-Selling Products are Reimagined for Today’s Clinical Lab

10/11/2022
Traceable’s research and development team conducted customer focus groups and industry conversations to learn how clinics, labs, academic institutions, logistics companies, and other organizations use Traceable products. The Traceable engineering team used this information to update four of Traceable’s top-selling products to be even more user-friendly, more economical, and higher performing than ever. Read More

ZeptoMetrix® Launches NATtrol™ Monkeypox Virus External Run Control

9/29/2022
Buffalo, NY, September 29, 2022 — ZeptoMetrix®, an Antylia Scientific™ company, launches NATtrol™ Monkeypox Virus External Run Control: NATMPXV-ERC. This third-party molecular quality control can be used by laboratories to evaluate and monitor the continued performance of their monkeypox virus PCR assays. Read More

First Step to In Vitro Diagnostic Regulation (IVDR) Certification for ZeptoMetrix®

9/23/2022
Buffalo, NY, September 22, 2022 — ZeptoMetrix®, an Antylia Scientific company, is proud to announce it has successfully completed its first EU Quality Management System Audit from British Standards Institution BSI, NB 2797, one of the notified bodies under the new In Vitro Diagnostics Regulation (IVDR). The certification applies to the portfolio of ZeptoMetrix NATtrol™ control products that are the industry’s preferred standard for molecular diagnostics testing and are supplied ready-to-use as independent third-party quality control materials. Read More

ZeptoMetrix® launches Recombinant Monkeypox Virus Stock

8/25/2022
Buffalo, NY, August 24 2022 — ZeptoMetrix®, an Antylia Scientific™ company, launches Recombinant Monkeypox Stock: 0831137. This product is intended to aid laboratories in the evaluation of nucleic acid tests designed to detect certain portions of the Monkeypox virus genome. Read More

New ZeptoMetrix® Flu/RSV/SARS-CoV-2 External Run Control is Now Available for Order

8/25/2022
Buffalo, NY, August 29, 2022 — The recently launched ZeptoMetrix® NATtrol™ external run control for Flu/RSV/SARS-CoV-2: NATFRC-ERC is now available for order and any pre-orders will be filled and shipped. This third-party molecular quality control can be used by laboratories to monitor the continued performance of their multiplexed respiratory assays. With target concentrations of 15,000 cp/mL for all four analytes, the launch of NATFRC-ERC represents an exciting addition to the ZeptoMetrix respiratory product line. “The flu season is here. It’s our top priority to make sure laboratories are equipped with the materials needed to accurately detect and differentiate the most common respiratory infections,” said Evangeline Gonzalez, Vice President/General Manager of ZeptoMetrix. Read More